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Abstract The 14-3-3 proteins comprise a family of highly 
conserved proteins with multiple functions, most of which are 
related to signal transduction. Four isoforms from the plant 
Arabidopsis thaliana were able to complement the lethal 
disruption of the two Saccharomyces cerevisiae genes encoding 
14-3-3 proteins; one complemented very poorly and one did not 
complement. However, the expression of the latter two isoforms 
was very low. These results show that at least four of the six 
A. thaliana isoforms are able to perform the same function(s) as 
the yeast 14-3-3 proteins. 
Key words: 14-3-3 Protein; BMH1; BMH2; GF14; 
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I. Introduction 
The 14-3-3 proteins comprise a family of acidic dimeric 
proteins with a subunit molecular mass of approx. 30 kDa 
[1-3]. These proteins are found in a wide variety of organisms 
including mammals [1--6], plants [7-9], Xenopus [10], Droso- 
phila [11], Dictyostelium discoideum (M. Knetch et al., manu- 
script in preparation) and yeast [12]. Most organisms contain 
multiple isoforms of these proteins. The amino acid sequences 
are well conserved throughout evolution. 
Many different activities have been ascribed to the 14-3-3 
proteins. The first reported function of the 14-3-3 proteins was 
a role as activator of tryptophan 5-monooxygenase and tyr- 
osine 3-monooxygenase in the presence of Ca 2+- and calmod- 
ulin-dependent protein kinase II [13]. This activation is re- 
quired for neurotransmitter synthesis [14]. Later, 14-3-3 
proteins which strongly inhibited protein kinase C were iso- 
lated from sheep brain [4,15]. Other groups observed a stimu- 
latory effect of 14-3-3 proteins on protein kinase C [16,17]. An 
arachidonic acid specific phospholipase A~, isolated from hu- 
man platelets, appeared to be a 14-3-3 protein [18]. A cyto- 
solic protein (exol) required for CaZ+-dependent exocytosis in 
permeabilized adrenal chromaffin cells also belongs to the 14- 
3-3 protein family [19]. A 14-3-3 protein from bovine brain 
activates exoerLzyme S (ExoS) of Pseudomonas aeruginosa, 
which ADP-ribosylates Ras and other host GTP-binding pro- 
teins [20]. 14-3-3 proteins from Arabidopsis thaliana and maize 
[9] were found associated with the G-box DNA/protein com- 
plex. In recent years, evidence has been provided that 14-3-3 
proteins bind to Raf protein kinases [21-25], BCR kinase 
[25,26], polyoma middle tumor antigen [27], a Ras-dependent 
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MAPKKK from bovine brain [28] and human cdc25 phos- 
phatases [29]. In the yeast Schizosaccharomyces pombe, 14-3-3 
proteins appear to be involved in DNA damage control dur- 
ing the cell cycle [30]. Finally, the plant receptor for the fungal 
toxin fusicoccin was shown to be a 14-3-3 protein [31,32]. 
Fractionation of a 14-3-3 protein fraction isolated from 
mammalian brain tissue revealed the existence of at least 
seven isoforms of these proteins [5,33-35]. Two of the iso- 
forms were shown to be a phosphorylated form of other iso- 
forms [36]. From the plant A. thaliana six different cDNAs 
encoding 14-3-3 protein isoforms have been isolated [37,38]. 
The yeast Saccharomyces cerevisiae has two genes, BMH1 and 
BMH2, coding for 14-3-3 proteins [12,39,40]. Previously, we 
showed that disruption of the BMH1 or the BMH2 gene 
alone had hardly any effect [12,39]. On the other hand, dis- 
ruption of both genes simultaneously is a lethal event [39]. 
Expression of a 14-3-3 isoform from A. thaliana (GF14-14) 
was able to complement the lethal double disruption. 
Despite the high conservation, it is not clear whether all 
isoforms perform all functions mentioned above or that spe- 
cific isoforms exist for the various activities. To investigate 
this question, we made use of the lethality of yeast mutants 
devoid of 14-3-3 proteins and tested whether all known A. 
thaliana isoforms were able to complement these mutations. 
In addition, the ability of the human theta isoform and the 
unique 14-3-3 protein from D. discoideum to complement was 
investigated. 
2. Materials and methods 
2.1. Strains, plasmids and culture media 
The yeast strains used in this study are: GG580, MATa/MATo~ 
leu2-3,112/leu2-3,112 ura3-52/ura3-52 trp1-92/trp1-92 his4~+ 
bmhl::LEU2/+ [39]; GG576, MATa/MATct leu2-3,112/leu2-3,112 
ura3-52/ura3-52 trp1-92/trp1-92 his4~+ bmhl ::LEU2/+ bmh2: :APT1~ 
+; GG1305, MATa leu2-3,112 ura3-52 trp1-92 his4 bmhl::LEU2 
bmh2: :APT1 (YCplac33[BMH1]); and GG1306, MATa leu2-3,112 
ura3-52 trp1-92 his4 bmhl ::LEU2 bmh2: :APT1 ~Cplac33[BMH2]). 
The Escherichia coli strain XLl-blue [41] was used for plasmid ampli- 
fication. Culture media for yeast and E. coli were described previously 
[39]. 
2.2. Nucleic acid manipulations 
DNA isolations were performed as described previously [39]. DNA 
was sequenced using an ALF DNA sequencer (Pharmacia). Double 
stranded DNA isolated with a Nucleobond DNA isolation kit (Mach- 
ery-Nagel, Dueren, Germany) was used for sequencing. 
2.3. Construction f the strains GG1305 and GG1306 
An internal 0.5 kb XmnI-BclI fragment of the BMH2 gene in 
pBlue[BMH2] was removed as described previously [39] and replaced 
by a 2.4 kb HinclI-BgllI fragment from pBEJ24 [42]. The latter frag- 
ment contains the APT1 gene under control of the PGK1 promoter 
and codes for resistance to geneticin (G418). The resulting plasmid 
was digested with EcoRI, yielding a 5.1 kb fragment containing the 
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disrupted BMH2 gene. This fragment was used to transform the dip- 
loid strain GG580 heterozygous for the BMH1 disruption [39] and 
G418 resistant colonies were selected. The correct disruption of the 
BMH2 gene was verified by Southern blot analysis. One of the trans- 
formants was selected (GG576) and transformed with the plasmid 
YCplac33[BMH1] [12] or YCplac33[BMH2]. The latter plasmid con- 
tains a 3.2 kb EcoRI fragment with the BMH2 gene [39]. From both 
transformations, one of the transformants was sporulated and leucine 
and uracil prototrophic G418 resistant haploids were selected. This 
resulted in the isolation of a haploid strain with a disrupted BMH1 
gene, a disrupted BMH2 gene carrying either the plasmid YC- 
plac33[BMH1], strain GG1305, or the plasmid YCplac33[BMH2], 
strain GG1306. The correct genotype was verified by Southern blot 
analysis. 
2.4. Construction ofp YES- TRP plasmids encoding 14-3-3 protein 
isoforms 
A 1.0 kb DNA fragment with the coding sequences of the BMH1 
gene was obtained from the plasmid pRS306[BMH1] [39] after diges- 
tion with EcoRI and XhoI. This fragment was ligated into the plasmid 
pYES2 (Invitrogen Corp.) digested with the same enzymes. The 
URA3 gene was replaced by the TRP1 gene as described previously 
[39] resulting in the plasmid pYES-TRP[BMH1]. Similarly, pYES- 
TRP was obtained from pYES2 by replacing the URA3 gene of 
pYES2 by the TRP1 gene. The coding sequences of the BMH2 gene 
were amplified by the PCR reaction using primers with a KpnI and 
Xhol site, respectively, and ligated into the pYES-TRP plasmid after 
digestion with KpnI and XhoI. pYES-TRP[GF14-14] was constructed 
as described previously [39]. pCRII plasmids containing the cDNAs 
encoding the GF14-5 and GF14-10 isoforms [37] were digested with 
Kpnl and XhoI and the cDNAs were ligated into pYES-TRP after 
digestion with the same enzymes. The cDNA encoding the GF14-4 
isoform [37] was released from the pCRII plasmid by digestion with 
PstI and SpeI and ligated into pRS305. Subsequently, it was ligated 
into pYES-TRP after digestion with KpnI and SacI. The cDNA en- 
coding the GF13-19 isoform was obtained by the PCR reaction on a 
plasmid preparation of an A. thaliana cDNA library in the vector 
pFL61 [43] using the primers: 5'AAGTCGACAAGATGTCTTCT- 
GATTC3' and 5'ATGTCGACAAATCACCCCATGGATC3'. These 
primers contain a SalI restriction site. The PCR product obtained was 
digested with SalI and ligated into pYES-TRP digested with XhoI. 
pBluescript containing the cDNA encoding the RCllB isoform [38] 
was digested with KpnI and BamHI and the cDNA was ligated into 
pUC18 after digestion with the same enzymes. The resulting plasmid 
was digested with KpnI and SalI and the cDNA was ligated into 
pYES-TRP digested with KpnI and XhoI. The cDNA encoding the 
human theta isoform [6] was obtained from Dr. A.M. Carr (MRC, 
Brighton, UK). It was ligated into the pYES-TRP plasmid after di- 
gestion with SacI and XhoI. All clones amplified by the PCR reaction 
were verified by sequencing. 
2.5. Complementation of the double disruptants 
Strains GG1305 and GG1306 were transformed [44] with the var- 
ious pYES-TRP plasmids and tryptophan prototrophic colonies were 
selected. For all transformations at least 100 transformants were ob- 
tained. Six colonies from each transformation were selected and after 
purification streaked on MYZ medium [39] containing galactose 
(1.5%, w/v), uracil (20 rag/l), histidine (20 mg/1) and 5-fluoroorotic 
acid (5-FOA) (1 mg/ml) and incubated for 5 days at 30°C. At least 
five colonies from each transformation gave identical results; one of 
these was selected for further studies. 
After selection for loss of the YCplac33[BMH2] plasmid on MYZ 
medium with galactose, histidine, uracil and 5-FOA, one colony was 
selected and after purification used for further studies. The presence of 
the correct plasmid was verified by isolation of the plasmid, followed 
by amplification i  E. coli. 
3. Results 
The cDNAs encoding the A. thaliana GF14-14, GF14-10, 
GF14-5, GF14-4, GF13-19 and RCL1B 14-3-3 protein iso- 
forms as well as the human theta isoform and the yeast 
BMH1 and BMH2 genes are placed under control of the yeast 
GALl promoter on the plasmid pYES-TRP (see Section 2). In 
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Fig. 1. Complementation f the bmhl bmh2 double disruptant by 
foreign 14-3-3 protein isoforms. 
order to investigate whether they can complement the lethal 
bmhl bmh2 double disruption, the plasmid shuffling technique 
was used. A haploid yeast strain (GG1305) was constructed in 
which the BMH1 gene was disrupted with the LEU2 gene and 
the BMH2 gene with the APT1 gene, carrying the plasmid 
YCplac33[BMH1] with an active BMH1 gene and the URA3 
selection marker (Fig. 1A). A similar strain (GG1306) was 
constructed carrying the plasmid YCplac33[BMH2] with an 
active BMH2 gene. These strains were transformed with the 
various pYES-TRP plasmids (Fig. 1B). The transformants 
were streaked on a plate containing minimal medium 
(MYZ) with galactose, 5-FOA, histidine and uracil. I f  the 
foreign 14-3-3 isoform can take over the function of the 
BMH1 or BMH2 gene on the plasmid, the yeast cells can 
lose the plasmid (with the URA3 gene) and form colonies 
on this medium (Fig. 1C). The results of a typical experiment 
using strains derived from GG1305 or from GG1306 are 
shown in Fig. 2A and B, respectively. It is clear that the 
BMH1 and BMH2 genes under control of the GALl promo- 
ter can complement the double disruption. Furthermore, the 
A. thaliana GF14-14, GF14-4, GF14-5 and RCL1B isoforms 
as well as the human theta isoform gave complementation. 
Also, the D. discoideum isoform complemented well (data 
not shown). For reasons unknown, the GF14-5 isoform 
gave smaller and a lower number of colonies (only visible 
after prolonged incubation) when expressed in the strain 
GG1306 compared to expression in GG1305. The A. thaliana 
GF13-19 isoform gave colonies only after very long incuba- 
tion (at least 14 days at 30°C). GF14-10 appeared not to 
complement under these conditions. 
After selection on MYZ medium with galactose, 5-FOA, 
uracil and histidine one colony was selected from each of 
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Fig. 2. Selection for growth on media with galactose in the presence of 5-FOA. Strains derived from GG1305 (A) or from GG1306 (B) by 
transformation with pYES-TRP plasmids encoding the isoforms indicated are streaked on plates containing MYZ medium with galactose, ura- 
cil, histidine and 5-FOA. E, pYES-TRP plasmid lacking a 14-3-3 protein isoform. 
the strains derived from GG1306. The colony was purified 
and the presence of the proper pYES-TRP plasmid was ver- 
ified by isolation of the plasmid after amplification i E. coli. 
All strains grew much slower on media with glucose instead of 
galactose (data not shown), indicating that the inducible 
GALl promoter is involved. To investigate the expression of 
the foreign 14-3-3 proteins, the various strains were grown in 
YP medium with galactose and the protein extracts were ana- 
lyzed by Western blotting (Fig. 3). Probed with the antiserum 
against he Bmhl protein, clear bands are visible in extracts 
from the strains containing the pYES-TRP plasmids with the 
Anti BMH1 
Anti GF14-14 
Fig. 3. Western blot analysis of the complemented double disrup- 
tants. Strains obtained after loss of the YCplac33[BMH2] plasmid 
were grown in YP medium containing alactose (1.5%, w/v) until an 
OD620 between 0.4 and 0.7. Cells were harvested by centrifugation, 
resuspended in water until a concentration of 500 OD620 units/m/. 
5 OD820 units were used for each lane. For the blot probed with 
the anti-BMH1 antiserum 0.05, 0.006 and 0.25 OD620 units of cells 
expressing BMH1, BMH2 or GF14-14, respectively, were used. Wes- 
tern blot analysis was performed as described previously [39] using 
a chemiluminescence kit from Boehringer. Blots were probed with 
either the rabbit anti-BMH1 antiserum [39] or a mouse monoclonal 
anti GF14-14 antiserum [8]. 
yeast BMH1 or BMH2 genes, with the A. thaliana GF14-14 
and GF14-5 cDNAs and with the human theta cDNA. As the 
Bmhl and Bmh2 proteins (31 and 32 kDa) are larger than the 
foreign 14-3-3 proteins (approx. 27 kDa) they can be distin- 
guished. It is clear that the Bmhl and Bmh2 proteins are 
absent from the strains expressing the foreign 14-3-3 isoforms. 
On a Western blot probed with a monoclonal antiserum 
raised against he GF14-14 protein no bands are visible in 
extracts from strains expressing the BMH1 or BMH2 gene. 
This confirms our previous observations that this antiserum 
does not detect he yeast 14-3-3 proteins [45]. Clear bands are 
visible after expression of the GF14-14, GF14-4 and GF14-5 
isoforms. Very weak bands are visible in extracts from strains 
expressing the GF13-19 and RCL1B isoform. The combined 
Western blot experiments indicate that the yeast BMH1 and 
BMH2 genes, the plant GF14-14, GF14-4 and GF14-5 
cDNAs and the human theta cDNA are expressed well in 
the bmhl bmh2 double disruptant. The plant GF13-19 
cDNA is probably expressed very poorly. As the RCI1B iso- 
form is more distinct from the other isoforms, it may be less 
reactive with the antisera used. 
4. Discussion 
A long list of activities has been ascribed to the 14-3-3 
proteins. As most eukaryotic organisms contain multiple iso- 
forms of the 14-3-3 proteins, the question arises whether each 
isoform has its own function or only a limited number of 
functions or whether a single isoform can fulfil all functions 
ascribed to the 14-3-3 proteins. In order to address this ques- 
tion, we investigated whether the six A. thaliana isoforms can 
complement the lethal yeast bmhl bmh2 double disruption. 
Four isoforms (GF14-14, GF14-4, GF14-5 and RCI1B) 
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clearly complemented the double disruption. One isoform 
(GF13-19) complemented very poorly. Only after a 2 weeks 
incubation are small colonies visible on plates with MYZ 
medium with galactose and 5-FOA. Growth rates in liquid 
media were very low and a large number of cells were im- 
paired in cytokinesis as we showed previously for cells lacking 
all 14-3-3 proteins [39]. Two independent cDNA clones en- 
coding the GF13-19 isoform were used which were ligated 
differently in the pYES-TRP plasmid and similar results 
were obtained (data not shown). No complementation was 
found for the GF14-10 isoform. Western blot experiments 
suggested that the expression of the GF13-19 and GF14-10 
isoforms is very low. It is still unclear why levels of these 
proteins are so low. Either expression is very low or, because 
the proteins are non-functional, proteins and/or RNAs  are 
rapidly degraded. The most obvious differences of the 
GF14-10 isoform compared to the other isoforms are its hy- 
drophobic N-terminus, and it contains a serine residue at 
position 125 whereas all other isoforms have an alanine resi- 
due at this position). The GF13-19 isoform has a serine resi- 
due at position 217, whereas the other isoforms have an ala- 
nine at this position. However, the significance of these 
sequence differences remains to be established. As comple- 
mentation was found for the human theta and the A. thaliana 
RCl lB isoform which are more distinct from the other iso- 
forms, quite a variation in amino acid sequences of the non- 
conserved regions are tolerated. 
This study shows that at least four A. thaliana isoforms can 
fulfil the same function(s) as the yeast Bmhl and Bmh2 pro- 
teins. This indicates that these isoforms are not highly specia- 
lized. However, it is still very well possible that in the plant 
when several different isoforms are present, the isoforms have 
more specialized functions due to subtle differences in affinity 
and/or selectivity of the different isoforms for their cellular 
targets. Previously, it was demonstrated that the GF14-14 iso- 
form was able to fulfil a number of activities ascribed to the 
14-3-3 proteins [45]. It was able to activate rat brain trypto- 
phan hydroxylase, protein kinase C and exoenzyme S from 
Pseudomonas aeruginosa, it binds Ca 2+ and it is present in the 
G-box binding factor. The other isoforms have been studied 
less thoroughly. Also, the human theta isoform and a D. dis- 
coideum isoform (data not shown) can complement the double 
disruption, suggesting that these isoforms are not very specia- 
lized as well. 
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